NO140669C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater og deres syreaddisjonsforbindelser - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater og deres syreaddisjonsforbindelser

Info

Publication number
NO140669C
NO140669C NO740845A NO740845A NO140669C NO 140669 C NO140669 C NO 140669C NO 740845 A NO740845 A NO 740845A NO 740845 A NO740845 A NO 740845A NO 140669 C NO140669 C NO 140669C
Authority
NO
Norway
Prior art keywords
analogical
procedures
preparation
therapeutically active
additional compounds
Prior art date
Application number
NO740845A
Other languages
English (en)
Norwegian (no)
Other versions
NO740845L (no
NO140669B (no
Inventor
Wolfgang Milkowski
Horst Zeugner
Klaus-Wolf Von Eickstedt
Werner Stuehmer
Original Assignee
Kali Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Ag filed Critical Kali Chemie Ag
Publication of NO740845L publication Critical patent/NO740845L/no
Publication of NO140669B publication Critical patent/NO140669B/no
Publication of NO140669C publication Critical patent/NO140669C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO740845A 1973-03-12 1974-03-11 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater og deres syreaddisjonsforbindelser NO140669C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2312171 1973-03-12

Publications (3)

Publication Number Publication Date
NO740845L NO740845L (no) 1974-09-13
NO140669B NO140669B (no) 1979-07-09
NO140669C true NO140669C (no) 1979-10-17

Family

ID=5874516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740845A NO140669C (no) 1973-03-12 1974-03-11 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater og deres syreaddisjonsforbindelser

Country Status (16)

Country Link
US (1) US3966735A (ja)
JP (1) JPS49125378A (ja)
AR (1) AR205657A1 (ja)
AT (1) AT339316B (ja)
BE (1) BE812134R (ja)
CA (1) CA1061789A (ja)
CH (3) CH591464A5 (ja)
DD (1) DD110874A5 (ja)
ES (1) ES423395A1 (ja)
FR (1) FR2221137B2 (ja)
GB (1) GB1445927A (ja)
IL (1) IL44390A (ja)
NL (1) NL7403163A (ja)
NO (1) NO140669C (ja)
SE (1) SE405972B (ja)
ZA (1) ZA741594B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194819B (it) * 1980-11-20 1988-09-28 Selvi & C Spa Derivati della piperazina,procedimento per la loro preparazione e relative composizioni farmaceutiche
ES8506679A2 (es) * 1984-01-17 1985-08-01 Ferrer Int Mejoras en el objeto de la patente de invencion n 514.340 que se refiere a: procedimiento de obtencion de nuevos derivados de piperazina
CN1181065C (zh) * 2002-05-08 2004-12-22 上海医药工业研究院 芳烷甲酰烷基哌嗪衍生物及其作为脑神经保护剂的应用
EP2027087A2 (en) 2006-05-18 2009-02-25 MannKind Corporation Intracellular kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2695293A (en) * 1952-12-19 1954-11-23 Mcneilab Inc N, n'-substituted diamine compounds and method of making the same
US2695295A (en) * 1952-12-19 1954-11-23 Mcneilab Inc Unsymmetrical n, n'-substituted ethylenediamine and piperazine compounds
US3000892A (en) * 1959-11-16 1961-09-19 Paul A J Janssen 1-aroylalkyl-4-aroylpiperazines
US3637704A (en) * 1967-10-18 1972-01-25 Dainippon Pharmaceutical Co 1gamma-(p-fluorobenzoyl)propyl-4-phenylalkyl piperazine
FR2047866B1 (ja) * 1969-06-03 1973-03-16 Ferlux

Also Published As

Publication number Publication date
IL44390A (en) 1978-01-31
CH591464A5 (ja) 1977-09-15
NO740845L (no) 1974-09-13
ES423395A1 (es) 1976-06-01
FR2221137B2 (ja) 1978-03-24
GB1445927A (en) 1976-08-11
SE405972B (sv) 1979-01-15
BE812134R (fr) 1974-09-11
JPS49125378A (ja) 1974-11-30
ATA200074A (de) 1977-02-15
AR205657A1 (es) 1976-05-21
NO140669B (no) 1979-07-09
US3966735A (en) 1976-06-29
DD110874A5 (ja) 1975-01-12
NL7403163A (ja) 1974-09-16
CH602687A5 (ja) 1978-07-31
IL44390A0 (en) 1974-06-30
AT339316B (de) 1977-10-10
CH603611A5 (ja) 1978-08-31
FR2221137A2 (ja) 1974-10-11
ZA741594B (en) 1975-03-26
AU6650974A (en) 1975-09-11
CA1061789A (en) 1979-09-04

Similar Documents

Publication Publication Date Title
NO140059B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinderivater
NO140056C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive olefinisk 4-substituerte piperidino-derivater
SE410595B (sv) Forfarande for framstellning av 4-(monoalkylamino)-bensoesyraderivat
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO142304C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO143846C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO140057C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivater
NO140978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO140821C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater
DK137239C (da) Fremgangsmaade til fremstilling af terapeutisk aktive 2-(3'-hydroxyphenyl)-1-oxa-4-azaspiroalkan-derivater
NO137550C (no) Analogifremgangsmaate til fremstilling av anti-inflammatorisk virksomme 2,4,5-trisubstituerte oksazolforbindelser
NO140858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 2,4-diamino-5-benzyl-pyrimidinderivater
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
NO140669C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater og deres syreaddisjonsforbindelser
NO139920C (no) Fremgangsmaate ved fremstilling av 2,5-disubstituerte benzamider
NO138561C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cykloalkylfenoksykarboksylsyrederivater
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
NO138250C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylaminer
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO136408C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser
NO741939A (no) Analogifremgangsmåte ved fremstilling av nye, terapeutisk aktive 3,4,5,6-tetrahydro(1,3)thiazolo(3,4-a)isokinolinderivater.
NO141121C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive morfolinderivater